Are Serum Levels of Vascular Endothelial Growth Factor a Marker for the Early Diagnosis of Ectopic Pregnancy? (UNIFESP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
OBJECTIVE: This study evaluated serum vascular endothelial growth factor (VEGF) concentrations in women with ectopic pregnancy (EP), abnormal intrauterine pregnancy (aIUP) and normal intrauterine pregnancy (nIUP).
METHODS: This was a prospective, case-control study comparing serum VEGF concentrations among 72 women with ectopic pregnancy (n=35), abnormal IUP (n=15) and normal IUP (n=22) matched for gestational age. For the determination of serum VEGF concentration a solid phase sandwich ELISA was used. Patients were stratified according to serum VEGF above or below 200pg/mL.
RESULTS: The serum level of VEGF was significantly higher in women with ectopic pregnancy (median 211.1 pg/mL; range 5 - 1017.0 pg/mL) than in women with normal IUP (median 5 pg/mL; range 5- 310.6 pg/mL) P < 0.0001. Serum VEGF concentrations did not show any statistically significant difference between women with aIUP (median 231.9 pg/mL range 5 - 813.7 pg /mL ) and EP (median 211.1 pg/mL range 5 - 1017.0 pg/mL). When cut-off concentrations of 200 pg/mL for VEGF were used, a nIUP could be distinguished from an unviable (EP and aIUP) with a sensitive of 53%, specificity of 90.9%, a positive predictive value of 92.9% and a negative predictive value of 46.5%..
CONCLUSIONS: Serum VEGF could not distinguish between an EP and an aIUP. However, serum VEGF concentrations above 200 pg/mL could discriminate a nIUP from an unviable pregnancy (EP or aIUP) with a PPV of 92.9%.
| Condition |
|---|
|
Ectopic Pregnancy |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Are Serum Levels of Vascular Endothelial Growth Factor a Marker for the Early Diagnosis of Ectopic Pregnancy? |
| Groups/Cohorts |
|---|
|
Ectopic pregnancy, extra-uterine pregnancy
Ectopic pregnancy, control
|
| Abnormal intrauterine pregnancy |
Eligibility| Ages Eligible for Study: | 15 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Sampling Method: | Non-Probability Sample |
ectopic pregnancy abnormal intrauterine pregnancy normal intrauterine pregnancy
Inclusion Criteria:The inclusion criterion was the presence at transvaginal ultrasound of an extraovarian adnexal mass in women with a suspected ectopic pregnancy (amenorrhea, bleeding and pain) with positive test for beta-hCG.
-
Exclusion Criteria:The exclusion criterion was non-tubal ectopic pregnancy (cervical, cesarean scar, ovarian, and abdominal).
-
Contacts and Locations
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT01261026 History of Changes |
| Other Study ID Numbers: | JEJ-060866 |
| Study First Received: | December 15, 2010 |
| Last Updated: | December 15, 2010 |
| Health Authority: | Brazil: Ethics Committee |
Additional relevant MeSH terms:
|
Pregnancy, Ectopic Cardiac Complexes, Premature Pregnancy Complications Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |
Mitogens Endothelial Growth Factors Mitosis Modulators Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Growth Substances Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on May 22, 2013